✦ LIBER ✦

High dose safety and pharmacokinetic study of ISIS 2302 in Crohn’s disease

✍ Scribed by Charles F Barish; John Goff; Douglas Dalke; Michael Gaspari; Joseph Tami; Lea Sewell; Bruce Yacyshyn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sefety of retreatment with antisense to

✍ Yacyshyn, B.R.; Bowen-Yacyshyn, M.B.; Tami, J.; Sahba, B.; Shanahan, W. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A randomized, placebo-controlled trial o

✍ Yacyshyn, Bruce R.; Chey, W.Y.; Goff, J; Salzberg, B; Baerg, R; Buchman, A.L.; T 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Multiple doses of intravenous interleuki

✍ SJ van Deventer; CO Elson; RN Fedorak 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Efficacy and safety of high-dose cabergo

✍ P. Odin; C. Oehlwein; A. Storch; U. Polzer; G. Werner; R. Renner; M. Shing; A. L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

High-dose dextromethorphan in amyotrophi

✍ Dr. Dave Hollander; Jesus Pradas; Richard Kaplan; Howard L. McLeod; William E. E 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Safety of prolonged low-dose alternate-d

✍ Dr. Theodore M. Bayless 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views